Iceland vs Ireland: Access to anti-retroviral drugs, male
Iceland
89.0%
in 2024
Ireland
89.0%
in 2023
Iceland rank
17th
Ireland rank
17th
Access to anti-retroviral drugs, male over time
- Iceland
- Ireland
How they compare
Iceland currently reports 89.0% against 89.0% in Ireland, a difference of 0.0%.
The two have swapped places 3 times across 24 shared years of data; in 2000 it was Ireland ahead.
Iceland ranks 17th and Ireland ranks 17th of 141 countries.
Ireland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iceland | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.3% | 47.1% | 1.8% | Ireland |
| 2010s | 68.6% | 71.4% | 2.8% | Ireland |
| 2020s | 85.8% | 87.5% | 1.8% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Iceland or Ireland?
- Iceland, at 89.0% against 89.0% in Ireland as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Iceland and Ireland?
- 0.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Ireland?
- 24 years are reported by both, from 2000 to 2023.
- How do Iceland and Ireland rank globally for access to anti-retroviral drugs, male?
- Iceland ranks 17th and Ireland ranks 17th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.